Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business
Published . Updated .
Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business Latham & Watkins LLP
Directly affected
- CLVT Clarivate
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- UNH UnitedHealth
A large health insurer
- JNJ Johnson & Johnson
A large health-care company
- LLY Eli Lilly
A large drug maker
- PFE Pfizer
A large drug maker
- AVXL ANAVEX LIFE SCIENCES CORP COM NEW
GA selected AVXL as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CAI CARIS LIFE SCIENCES INC COM
GA selected CAI as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- SLS SELLAS LIFE SCIENCES GROUP INC COM NEW
GA selected SLS as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ACHV ACHIEVE LIFE SCIENCE INC
GA selected ACHV as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business Latham & Watkins LLP
Source: Latham & Watkins LLP
Price since this story was published: Anavex Life Sciences (AVXL)
Since the first closing price after “Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business,” Anavex Life Sciences (AVXL) is -15.82%. The S&P 500 fund (SPY) is -1.47% over the same days, a -14.36% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Achieve Life Sciences (ACHV) | that day | -4.66% | final price |
| Achieve Life Sciences (ACHV) | the next day | -5.40% | final price |
| Achieve Life Sciences (ACHV) | two days later | -5.54% | final price |
| Achieve Life Sciences (ACHV) | three days later | -5.74% | final price |
| Achieve Life Sciences (ACHV) | three days earlier | -2.23% | final price |
| Achieve Life Sciences (ACHV) | five days earlier | -5.33% | final price |
| Anavex Life Sciences (AVXL) | that day | +2.36% | final price |
| Anavex Life Sciences (AVXL) | the next day | 0.00% | final price |
| Anavex Life Sciences (AVXL) | two days later | +1.01% | final price |
| Anavex Life Sciences (AVXL) | three days later | -1.01% | final price |
| Anavex Life Sciences (AVXL) | three days earlier | +3.37% | final price |
| Anavex Life Sciences (AVXL) | five days earlier | +10.44% | final price |
| Caris Life Sciences (CAI) | that day | +0.13% | final price |
| Caris Life Sciences (CAI) | the next day | -0.42% | final price |
| Caris Life Sciences (CAI) | two days later | +1.90% | final price |
| Caris Life Sciences (CAI) | three days later | +7.06% | final price |
| Caris Life Sciences (CAI) | three days earlier | -8.66% | final price |
| Caris Life Sciences (CAI) | five days earlier | +2.49% | final price |
| JNJ | that day | +0.88% | final price |
| JNJ | the next day | -4.91% | final price |
| JNJ | two days later | -2.88% | final price |
| JNJ | three days later | -3.12% | final price |
| JNJ | three days earlier | -1.14% | final price |
| JNJ | five days earlier | -3.26% | final price |
| LLY | that day | +0.28% | final price |
| LLY | the next day | -1.08% | final price |
| LLY | two days later | +2.50% | final price |
| LLY | three days later | +6.13% | final price |
| LLY | three days earlier | +0.80% | final price |
| LLY | five days earlier | -3.07% | final price |
Who gains and who loses around Anavex Life Sciences (AVXL)
Companies tied to this story
- AVXL Anavex Life Sciences
Anavex Life Sciences (AVXL) is linked, with no stored direction, medium confidence in the 12 Oct 2026 story “Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business.” Reason on file: GA selected AVXL as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CAI Caris Life Sciences
Caris Life Sciences (CAI) is linked, with no stored direction, medium confidence in the 12 Oct 2026 story “Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business.” Reason on file: GA selected CAI as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- SLS SELLAS Life Sciences Group
For “Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business,” SELLAS Life Sciences Group (SLS) is linked, with no stored direction, medium confidence. Reason on file: GA selected SLS as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACHV Achieve Life Sciences
In “Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business,” Achieve Life Sciences (ACHV) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHV as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- HQL abrdn Life Sciences Investors
In “Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business,” abrdn Life Sciences Investors (HQL) is linked, with no stored direction, medium confidence. Reason on file: GA selected HQL as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- TLSA Tiziana Life Sciences
Tiziana Life Sciences (TLSA) is linked, with no stored direction, medium confidence in the 12 Oct 2026 story “Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business.” Reason on file: GA selected TLSA as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Anavex Life Sciences (AVXL)
The 12 Oct 2026 story “Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business” names Anavex Life Sciences (AVXL) because of this story.
Anavex Life Sciences (AVXL) is on the page because GA selected AVXL as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Caris Life Sciences (CAI) is here too. Its reason reads: GA selected CAI as a RELATED security because its canonical security name directly matches this event's themes: sciences, life. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates and price levels for Anavex Life Sciences (AVXL)
AVXL traded between 1.15 and 2.48 across 20 sessions. The latest close on file is 1.25. CAI traded between 25.89 and 32.87 across 20 sessions. The latest close on file is 30.71. SLS traded between 9.76 and 12.69 across 20 sessions. The latest close on file is 10.49.
What the saved facts support for Anavex Life Sciences (AVXL)
46 out of 100
“Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.